Panacea Biotec consolidated net profit declines 11.95% in the December 2025 quarter
(12 Feb 2026)

Back
Net profit of Panacea Biotec declined 11.95% to Rs 3.98 crore in the quarter ended December 2025 as against Rs 4.52 crore during the previous quarter ended December 2024. Sales rose 1.04% to Rs 165.19 crore in the quarter ended December 2025 as against Rs 163.49 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales165.19163.49 1
OPM %7.114.87 -
PBDT12.1710.59 15
PBT3.721.61 131
NP3.984.52 -12

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew